EMEA Unaffected By Docklands Bombing

19 February 1996

Business at the European Medicines Evaluation Agency has not been affected by the massive explosion which occurred in London's Docklands on Friday february 9, killing two people and injuring more than 100.

EMEA staff told the Marketletter early last week that Agency's offices had not been affected, the only problem being restrictions on traffic movements around Westferry Circus in the aftermath of the blast, which was caused by an IRA bomb concealed in a truck parked close to South Quay subway station.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight